Kidney Neoplasms: all 973 studies

Page 10 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy in Treating Patients With Advanced Kidney CancerCompletedNCT00011973Phase 2
• Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney CancerCompletedNCT00006968Phase 1/2
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00006864Phase 4
• Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the LungCompletedNCT00006483Phase 2
• SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00006384Phase 2
• R115777 in Treating Patients With Advanced Bladder CancerCompletedNCT00006376Phase 2
• SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00006351Phase 2
• Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and MetastasesCompletedNCT00006255Phase 2
• Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWithdrawnNCT00006126Phase 1
• Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractCompletedNCT00006111Phase 2
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractCompletedNCT00006026Phase 2
• Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerCompletedNCT00006022Phase 1
• AE-941 in Treating Patients With Metastatic Kidney CancerCompletedNCT00005995Phase 3
• Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00005816Phase 1
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
• Arsenic Trioxide in Treating Patients With Metastatic Kidney CancerCompletedNCT00005069Phase 2
• Bryostatin 1 In Treating Patients With Progressive Kidney CancerCompletedNCT00005056Phase 2
• Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerCompletedNCT00005045Phase 2
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00005038Phase 2
• Rebeccamycin Analog in Treating Patients With Advanced Kidney CancerCompletedNCT00005027Phase 2
• Biomed 101 and Interleukin-2 in Treating Patients With Kidney CancerCompletedNCT00004890Phase 1
• Vaccine Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00004880Phase 1
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerCompletedNCT00004879Phase 1
• Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant MelanomaCompletedNCT00004244Phase 1
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
• Oxaliplatin in Treating Patients With Metastatic Bladder CancerCompletedNCT00004203Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerCompletedNCT00004135Phase 2
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Kidney CancerCompletedNCT00003968Phase 2
• Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney CancerCompletedNCT00003928Phase 2
• Dolastatin 10 in Treating Patients With Advanced Kidney CancerCompletedNCT00003914Phase 2
• Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' TumorStatus unknownNCT00003804Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Kidney CancerCompletedNCT00003683Phase 2
• Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed SurgicallyStatus unknownNCT00003664Phase 2
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With SurgeryStatus unknownNCT00003604Phase 2
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerCompletedNCT00003585Phase 1/2
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCompletedNCT00003584Phase 2
• Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00003553Phase 2
• Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney CancerCompletedNCT00003551Phase 2
• Interferon Alfa in Treating Patients With Advanced Kidney CancerCompletedNCT00003542Phase 1/2
• Antineoplaston Therapy in Treating Patients With Stage IV Kidney CancerTerminatedNCT00003520Phase 2
• 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerCompletedNCT00003390Phase 2
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00003181Phase 2
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder CancerCompletedNCT00003175Phase 2
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00003126Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
• High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaCompletedNCT00003091Phase 2
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00002914Phase 2
• Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00002847Phase 2
• Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney CancerStatus unknownNCT00002846Phase 2
• Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
• Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney CancerCompletedNCT00002737Phase 3
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00002733Phase 2
• Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00002641Phase 3
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney CancerCompletedNCT00002611Phase 3
• Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney TumorsCompletedNCT00002610Phase 3
• Lymphocyte Therapy in Treating Patients With Kidney CancerStatus unknownNCT00002589Phase 2
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerCompletedNCT00002475Phase 2
• Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerCompletedNCT00002473Phase 3
• Von Hippel-Lindau Disease Genetic Epidemiology StudyTerminatedNCT00001803
• Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal CancerCompletedNCT00001570Phase 1
• A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001302Phase 1

← Kidney Neoplasms overview